These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 19769452

  • 1. Adverse effects of medications commonly used in the treatment of migraine.
    Whyte CA, Tepper SJ.
    Expert Rev Neurother; 2009 Sep; 9(9):1379-91. PubMed ID: 19769452
    [Abstract] [Full Text] [Related]

  • 2. Preventive treatment of migraine.
    Silberstein SD.
    Rev Neurol Dis; 2005 Sep; 2(4):167-75. PubMed ID: 16622394
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Migraine drug therapy: dental implications.
    Jeske AH.
    Tex Dent J; 2006 Feb; 123(2):190-7. PubMed ID: 16579506
    [Abstract] [Full Text] [Related]

  • 5. A systematic review of adverse events in placebo groups of anti-migraine clinical trials.
    Amanzio M, Corazzini LL, Vase L, Benedetti F.
    Pain; 2009 Dec; 146(3):261-269. PubMed ID: 19781854
    [Abstract] [Full Text] [Related]

  • 6. [Acute migraine medications and evolution from episodic to chronic migraine].
    Haag G.
    MMW Fortschr Med; 2009 Feb 05; 151(6):41, 43. PubMed ID: 19432251
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment guidelines for acute migraine attacks].
    Treatment Guideline Subcommittee of Taiwan Headache Society.
    Acta Neurol Taiwan; 2007 Dec 05; 16(4):251-68. PubMed ID: 18220021
    [Abstract] [Full Text] [Related]

  • 9. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.
    Schulman EA, Lake AE, Goadsby PJ, Peterlin BL, Siegel SE, Markley HG, Lipton RB.
    Headache; 2008 Jun 05; 48(6):778-82. PubMed ID: 18484982
    [Abstract] [Full Text] [Related]

  • 10. Almotriptan in triptan-naïve patients: new evidence of benefits.
    Pascual J.
    Cephalalgia; 2008 Sep 05; 28 Suppl 2():14-20. PubMed ID: 18715328
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overview of diagnosis and treatment of migraine.
    Silberstein SD, Lipton RB.
    Neurology; 1994 Oct 05; 44(10 Suppl 7):S6-16. PubMed ID: 7969947
    [Abstract] [Full Text] [Related]

  • 16. Triptan migraine treatments and antidepressants: risk of serotonin syndrome.
    Wooltorton E.
    CMAJ; 2006 Oct 10; 175(8):874. PubMed ID: 16988028
    [No Abstract] [Full Text] [Related]

  • 17. Acute drug treatment of migraine attack.
    Narbone MC, Abbate M, Gangemi S.
    Neurol Sci; 2004 Oct 10; 25 Suppl 3():S113-8. PubMed ID: 15549517
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.